Management of Chronic Viral Hepatitis (PDF)
(Sprache: Englisch)
Hepatitis, the leading indication for liver transplantation, is a straight-forward disease when it comes to diagnosis: it is a disease of pathology and is diagnosed by liver biopsy, with the result being either positive or negative. There is only one...
Leider schon ausverkauft
eBook
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Management of Chronic Viral Hepatitis (PDF)“
Hepatitis, the leading indication for liver transplantation, is a straight-forward disease when it comes to diagnosis: it is a disease of pathology and is diagnosed by liver biopsy, with the result being either positive or negative. There is only one effective treatment: interferons. Nonetheless, new interferons are appearing on the market and Drs Foster and Goldin examine the use of each of these in the management of chronically infected patients. The authors have written a succinct, highly illustrated text for all those interested in the management of viral hepatitis.
Lese-Probe zu „Management of Chronic Viral Hepatitis (PDF)“
6 Combined infectionsSimultaneous infection with more than one virus is unusual, probably because the host defences are activated by the .rst virus and are then primed and ready to prevent further infections. As discussed in Chapter 1, hepatotropic viruses are able to avoid the host defence systems and this allows infection with multiple different viruses. Even so, patients with more than one infection are uncommon and, in general, the presence of more than one pathogen accelerates disease progression.
Hepatitis delta virus
The hepatitis delta virus is a unique human pathogen that needs the hepatitis B virus to infect cells and cause disease. Hepatitis delta virus is unable to cause infection on its own because it lacks an envelope protein, and the virus requires the surface antigen of the hepatitis B virus in order to propagate itself.
The virus and its replication
The hepatitis delta virus consists of a circular RNA genome that encodes a single protein, the delta antigen. The virus replicates in an unusual fashion that is similar to the process used by plant viroids. The viral RNA is duplicated in a rolling circle mechanism in which antigenomic RNA is produced in a long chain; the long chain of multiple, joined viral genomes is then cleaved by a ribozyme. Ribozymes are enzymes that are formed by loops of RNA and are able to process RNA hence the hepatitis delta virus RNA is able to form loops that cleave the viral RNA during replication. This unusual replication is an attractive target for the development of antiviral drugs but, to date, none that targets the hepatitis delta virus ribozyme has been developed. The replication of hepatitis delta virus is thought to be regulated by the single protein that it produces, the hepatitis delta antigen. This protein is found in cells in two different forms:
a small form that enhances viral replication; and
a large form that inhibits
... mehr
it.
During hepatitis delta virus replication, the viral genome undergoes a specific nucleotide conversion that changes a uridine to a cytosine at position 1015. This conversion changes the termination codon of the small hepatitis delta antigen and allows RNA translation to continue and so produce the large hepatitis delta antigen. Hence, during replication, the virus changes its genome to allow the production of the inhibitory form of hepatitis delta antigen and then regulates its own replication.
What controls the switch from the small to the large form of hepatitis delta antigen is unclear. Once the hepatitis delta virus RNA has duplicated itself, the new RNA is bound to the hepatitis delta antigen and then packaged into viral particles that are surrounded by the envelope protein of the hepatitis B virus. The virus is then released from the cell using unknown exit pathways.
Natural history of hepatitis delta virus infection
Infection with the hepatitis delta virus is unusual and is common in only a few geographical areas, chie.y the Mediterranean area and South America. The virus can infect only those patients who are co-infected with hepatitis B virus, and two patterns of infection occur:
co-infection, where both viruses are acquired together; and
superinfection, where a person who already has chronic hepatitis B virus
infection acquires hepatitis delta virus.
In co-infection a severe, acute hepatitis develops that may lead to liver failure requiring transplantation. If the patient survives the initial infection, both viruses are usually eliminated and no further therapy is required. Chronic, persistent infection develops in less than 10% of these patients. Superinfection with hepatitis delta virus also causes an acute hepatitis and, again, acute liver failure may develop, although this is less common. In contrast to coinfection, in which chronic infection is rare, most patients who are superinfected with hepatitis delta virus go on to develop persistent infection (chronic hepatitis delta). In chronic hepatitis delta virus infection, both hepatitis B virus and hepatitis delta virus persist in the liver.
The natural history of this infection is variable and differs in different geographical regions. In Italy and most other countries chronic hepatitis delta virus infection usually causes an aggressive hepatitis that progresses to cirrhosis within a relatively few years. However, on the Mediterranean island of Rhodes, hepatitis delta virus infection is common and usually leads to a mild disease that progresses very slowly. In South America, outbreaks of infection occur in which large numbers of people are infected. It is not clear whether these differences in transmission and outcome are due to different viral species or whether they are due to genetic differences in the host population.
During hepatitis delta virus replication, the viral genome undergoes a specific nucleotide conversion that changes a uridine to a cytosine at position 1015. This conversion changes the termination codon of the small hepatitis delta antigen and allows RNA translation to continue and so produce the large hepatitis delta antigen. Hence, during replication, the virus changes its genome to allow the production of the inhibitory form of hepatitis delta antigen and then regulates its own replication.
What controls the switch from the small to the large form of hepatitis delta antigen is unclear. Once the hepatitis delta virus RNA has duplicated itself, the new RNA is bound to the hepatitis delta antigen and then packaged into viral particles that are surrounded by the envelope protein of the hepatitis B virus. The virus is then released from the cell using unknown exit pathways.
Natural history of hepatitis delta virus infection
Infection with the hepatitis delta virus is unusual and is common in only a few geographical areas, chie.y the Mediterranean area and South America. The virus can infect only those patients who are co-infected with hepatitis B virus, and two patterns of infection occur:
co-infection, where both viruses are acquired together; and
superinfection, where a person who already has chronic hepatitis B virus
infection acquires hepatitis delta virus.
In co-infection a severe, acute hepatitis develops that may lead to liver failure requiring transplantation. If the patient survives the initial infection, both viruses are usually eliminated and no further therapy is required. Chronic, persistent infection develops in less than 10% of these patients. Superinfection with hepatitis delta virus also causes an acute hepatitis and, again, acute liver failure may develop, although this is less common. In contrast to coinfection, in which chronic infection is rare, most patients who are superinfected with hepatitis delta virus go on to develop persistent infection (chronic hepatitis delta). In chronic hepatitis delta virus infection, both hepatitis B virus and hepatitis delta virus persist in the liver.
The natural history of this infection is variable and differs in different geographical regions. In Italy and most other countries chronic hepatitis delta virus infection usually causes an aggressive hepatitis that progresses to cirrhosis within a relatively few years. However, on the Mediterranean island of Rhodes, hepatitis delta virus infection is common and usually leads to a mild disease that progresses very slowly. In South America, outbreaks of infection occur in which large numbers of people are infected. It is not clear whether these differences in transmission and outcome are due to different viral species or whether they are due to genetic differences in the host population.
... weniger
Bibliographische Angaben
- Autoren: Graham Foster , Robert D Goldin
- 2001, Englisch
- Verlag: Taylor & Francis Group Plc
- ISBN-10: 020344521X
- ISBN-13: 9780203445211
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "Management of Chronic Viral Hepatitis"
0 Gebrauchte Artikel zu „Management of Chronic Viral Hepatitis“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Management of Chronic Viral Hepatitis".
Kommentar verfassen